Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Atherosclerosis is the leading cause of death in the developed world. While a number of risk factors for atherosclerosis have been defined, scientists continue to study other possible risk factors for this disease. Recent epidemiological and experimental studies link infectious agents with the development of inflammatory atherosclerosis. A hallmark of chronic infection with the oral pathogen Porphyromonas gingivalis is the induction of a chronic inflammatory response.

5 Jan 2011

Anti-tobacco laws can reduce smoking habits in Europe

The Global Alliance for Chronic Diseases has announced its intention to release a Request for Applications on Implementation Research on Hypertension in Low and Middle Income Countries.

5 Jan 2011

Anaphylatoxin C5a may be responsible for devastating effects of atherosclerosis

For decades, doctors have looked at fitness levels, weight, and overall health risk factors for heart disease and stroke. Now, they may soon add a new risk factor to the list: activation of the complement system. The complement system is usually implicated in immune responses, but now there's a role for it in cardiovascular disease.

5 Jan 2011

Santaris Pharma, Pfizer expand RNA-targeted medicine collaboration

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, and Pfizer Inc., today announced that the companies have expanded their collaboration directed to the development and commercialization of RNA-targeted medicines using Santaris Pharma A/S Locked Nucleic Acid (LNA) Drug Platform.

5 Jan 2011

Diet low in micronutrients can contribute to metabolic syndrome

Results of an epidemiological study conducted by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and the Corporacion Ecuatoriana de Biotecnologia showed that the metabolic syndrome, a condition that increases a person's risk of developing cardiovascular disease and type 2 diabetes, was prevalent in a low-income urban community in Ecuador and that a poor diet low in micronutrients appeared to contribute.

5 Jan 2011

Eighth Annual CTO Summit and Left Main Coronary Interventions Course to be held Feb. 14-16, in New York City

The Eighth Annual Chronic Total Occlusion Summit and Left Main Coronary Interventions Course is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.

4 Jan 2011

Low-fat lupin proteins

In emerging countries such as China or Brazil, meat consumption is rising dramatically. Indeed, worldwide consumption of red meat has quadrupled since 1961. The United Nations Food and Agriculture Organization (FAO) expects increasing prosperity to lead to a doubling of global meat production by the year 2050. The question is whether our planet, with its limited farmland resources, will still be able to meet all of our needs into the future.

4 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

Depression and diabetes linked to increased risk of death from heart disease in women

Depression and diabetes appear to be associated with a significantly increased risk of death from heart disease and risk of death from all causes over a six-year period for women, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

An international team of researchers led by Daniel J. Rader, MD, associate director of Penn Medicine's Institute for Translational Medicine and Therapeutics, has received a $6 million grant from the Paris-based Fondation Leducq to study the molecular genetics of atherosclerotic cardiovascular disease. The team's proposal, "Molecular Mechanisms of Novel Genes Associated with Plasma Lipids and Cardiovascular Disease," was selected to receive the award through the Fondation's Transatlantic Networks of Excellence Program.

4 Jan 2011

Study: Multitude of genes are linked to adult height

As much as 90 percent of variation in adult height may be caused by genetic inheritance, but a multitude of genes are involved. Most of these have yet to be discovered.

4 Jan 2011

Fear of the fat promoted to curb obesity

The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body’s internal organs. The AMA’s proposals are part of a submission calling for $63 million to fight obesity.

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

MedCath completes sale of TexSan Heart Hospital to Methodist Healthcare System

MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.

3 Jan 2011

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.

3 Jan 2011

Mediterranean diet helps more than one chronic condition

In a study that was published in the Oct 13, 2001 issue of Diabetes Care, authors had reported that Mediterranean diet can reduce the risk of developing diabetes significantly. Those on this diet were 52 percent less likely to develop diabetes, compared with those who adhered least to the diet. Salas-Salvadó J. of Universitat Rovira i Virgili in Reus, Spain and colleagues compared two groups of subjects following two Mediterranean diets, one with nuts at 30 grams per day and the other with olive oil at 1 liter per week, with those on a low-fat diet.

2 Jan 2011

Team care to help multiple chronic conditions

According to a new study patients with multiple chronic diseases like diabetes mellitus and heart disease are at higher risk of depression that can render medication ineffective. Lead researcher Dr. Wayne J. Katon and colleagues at University of Washington in the study found that patients who received care from nurses who worked with patients and physicians to manage the care for depression and diabetes and heart disease had better outcomes. The study was published in the Dec 30, 2010 issue of New England Journal of Medicine.

2 Jan 2011

Experimental device for obstructive sleep apnea

Obstructive sleep apnea, a dangerous sleep disorder that affects millions of Americans may have found a cure. The disease commonly manifested as snoring but leading to tremendous sleep deprivation can be severely debilitating. Sleep deprivation may lead to car crashes, accidents, high blood pressure, heart attack, stroke, and diabetes.

29 Dec 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Anti-tobacco laws can reduce smoking habits in Europe

Anaphylatoxin C5a may be responsible for devastating effects of atherosclerosis

Santaris Pharma, Pfizer expand RNA-targeted medicine collaboration

Diet low in micronutrients can contribute to metabolic syndrome

Eighth Annual CTO Summit and Left Main Coronary Interventions Course to be held Feb. 14-16, in New York City

Low-fat lupin proteins

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

Depression and diabetes linked to increased risk of death from heart disease in women

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

Study: Multitude of genes are linked to adult height

Fear of the fat promoted to curb obesity

Deceptive food labels lead to increased risk of deadly diseases

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

MedCath completes sale of TexSan Heart Hospital to Methodist Healthcare System

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Mediterranean diet helps more than one chronic condition

Team care to help multiple chronic conditions

Experimental device for obstructive sleep apnea

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in